Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1952 1
1954 2
1955 3
1957 2
1958 2
1959 1
1960 2
1961 3
1962 4
1963 5
1964 4
1965 7
1966 19
1967 7
1968 10
1969 15
1970 18
1971 15
1972 14
1973 15
1974 22
1975 16
1976 14
1977 17
1978 25
1979 30
1980 39
1981 25
1982 33
1983 37
1984 32
1985 40
1986 58
1987 52
1988 42
1989 76
1990 93
1991 87
1992 96
1993 99
1994 130
1995 122
1996 100
1997 104
1998 110
1999 122
2000 141
2001 134
2002 113
2003 158
2004 156
2005 167
2006 153
2007 134
2008 142
2009 154
2010 159
2011 185
2012 188
2013 183
2014 213
2015 189
2016 196
2017 186
2018 229
2019 236
2020 258
2021 260
2022 240
2023 200
2024 207

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,890 results

Results by year

Filters applied: . Clear all
Page 1
Datopotamab Deruxtecan, a Novel TROP2-directed Antibody-drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells.
Okajima D, Yasuda S, Maejima T, Karibe T, Sakurai K, Aida T, Toki T, Yamaguchi J, Kitamura M, Kamei R, Fujitani T, Honda T, Shibutani T, Muramatsu S, Nakada T, Goto R, Takahashi S, Yamaguchi M, Hamada H, Noguchi Y, Murakami M, Abe Y, Agatsuma T. Okajima D, et al. Among authors: yamaguchi m. Mol Cancer Ther. 2021 Dec;20(12):2329-2340. doi: 10.1158/1535-7163.MCT-21-0206. Epub 2021 Aug 19. Mol Cancer Ther. 2021. PMID: 34413126 Free PMC article.
Drosophila as a Model Organism.
Yamaguchi M, Yoshida H. Yamaguchi M, et al. Adv Exp Med Biol. 2018;1076:1-10. doi: 10.1007/978-981-13-0529-0_1. Adv Exp Med Biol. 2018. PMID: 29951811 Review.
Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial.
Röth A, Berentsen S, Barcellini W, D'Sa S, Jilma B, Michel M, Weitz IC, Yamaguchi M, Nishimura JI, Vos JMI, Storek M, Wong N, Patel P, Jiang X, Vagge DS, Wardęcki M, Shafer F, Lee M, Broome CM. Röth A, et al. Among authors: yamaguchi m. Blood. 2022 Sep 1;140(9):980-991. doi: 10.1182/blood.2021014955. Blood. 2022. PMID: 35687757 Free PMC article. Clinical Trial.
Editorial: Host-Pathogen Interactions During Pneumococcal Infection.
Yamaguchi M, Kinjo Y, Nizet V. Yamaguchi M, et al. Front Cell Infect Microbiol. 2021 Oct 25;11:752959. doi: 10.3389/fcimb.2021.752959. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34760720 Free PMC article. No abstract available.
Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM).
Niikura N, Yamanaka T, Nomura H, Shiraishi K, Kusama H, Yamamoto M, Matsuura K, Inoue K, Takahara S, Kita S, Yamaguchi M, Aruga T, Shibata N, Shimomura A, Ozaki Y, Sakai S, Kiga Y, Izutani T, Shiosakai K, Tsurutani J. Niikura N, et al. Among authors: yamaguchi m. NPJ Breast Cancer. 2023 Oct 11;9(1):82. doi: 10.1038/s41523-023-00584-5. NPJ Breast Cancer. 2023. PMID: 37821514 Free PMC article.
A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B-cell lymphoma.
Terui Y, Rai S, Izutsu K, Yamaguchi M, Takizawa J, Kuroda J, Ishikawa T, Kato K, Suehiro Y, Fukuhara N, Ohmine K, Goto H, Yamamoto K, Kanemura N, Ueda Y, Ishizawa K, Kumagai K, Kawasaki A, Saito T, Hashizume M, Shibayama H. Terui Y, et al. Among authors: yamaguchi m. Cancer Sci. 2021 Jul;112(7):2845-2854. doi: 10.1111/cas.14937. Epub 2021 Jun 4. Cancer Sci. 2021. PMID: 33942442 Free PMC article. Clinical Trial.
The Japanese Epidemiologic Study for Perioperative Anaphylaxis, a prospective nationwide study: allergen exposure, epidemiology, and diagnosis of anaphylaxis during general anaesthesia.
Takazawa T, Horiuchi T, Nagumo K, Sugiyama Y, Akune T, Amano Y, Fukuda M, Haraguchi T, Ishibashi C, Kanemaru E, Kato T, Katoh K, Kawano T, Kochiyama T, Kuri M, Kurita A, Matsuoka Y, Muramatsu T, Orihara M, Saito Y, Sato N, Shiraishi T, Suzuki K, Takahashi M, Takahashi T, Tanabe K, Tomioka A, Tomita Y, Tsuji T, Watanabe I, Yamada T, Yoshida N, Yamaguchi M, Saito S. Takazawa T, et al. Among authors: yamaguchi m. Br J Anaesth. 2023 Jul;131(1):159-169. doi: 10.1016/j.bja.2023.02.018. Epub 2023 Mar 27. Br J Anaesth. 2023. PMID: 36990827 Free article.
Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study.
Abdelmalek MF, Sanyal AJ, Nakajima A, Neuschwander-Tetri BA, Goodman ZD, Lawitz EJ, Harrison SA, Jacobson IM, Imajo K, Gunn N, Halegoua-DeMarzio D, Akahane T, Boone B, Yamaguchi M, Chatterjee A, Tirucherai GS, Shevell DE, Du S, Charles ED, Loomba R. Abdelmalek MF, et al. Among authors: yamaguchi m. Clin Gastroenterol Hepatol. 2024 Jan;22(1):113-123.e9. doi: 10.1016/j.cgh.2023.04.012. Epub 2023 Apr 23. Clin Gastroenterol Hepatol. 2024. PMID: 37088458 Free article. Clinical Trial.
5,890 results